The latest recall affects a generic versions of the statin medication Atorvastatin Calcium, a medication taken by around 47 ...
MedPage Today on MSN
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...
This drug, marketed for other uses, is drawing young adults into devastating addictions -and sometimes fatal consequences.
MiBolsilloColombia on MSN
These are the FDA recall classifications according to their sense of urgency
Class I (death/injury risk) is most urgent. Class II (reversible harm possible). Class III (low risk, unlikely harm).
Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results